- Home
- COO vs NLY Comparison
COO vs NLY Comparison
Compare COO & NLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COO
- NLY
- Stock Information
- Founded
- COO 1980
- NLY 1996
- Country
- COO United States
- NLY United States
- Employees
- COO N/A
- NLY N/A
- Industry
- COO Ophthalmic Goods
- NLY Real Estate Investment Trusts
- Sector
- COO Health Care
- NLY Real Estate
- Exchange
- COO Nasdaq
- NLY Nasdaq
- Market Cap
- COO 14.6B
- NLY 13.2B
- IPO Year
- COO N/A
- NLY 1997
- Fundamental
- Price
- COO $68.47
- NLY $20.67
- Analyst Decision
- COO Buy
- NLY Buy
- Analyst Count
- COO 9
- NLY 11
- Target Price
- COO $96.89
- NLY $21.00
- AVG Volume (30 Days)
- COO 2.1M
- NLY 6.7M
- Earning Date
- COO 08-27-2025
- NLY 07-23-2025
- Dividend Yield
- COO N/A
- NLY 13.61%
- EPS Growth
- COO 21.77
- NLY N/A
- EPS
- COO 2.07
- NLY 1.00
- Revenue
- COO $3,988,200,000.00
- NLY $1,071,444,000.00
- Revenue This Year
- COO $6.84
- NLY $337.55
- Revenue Next Year
- COO $6.44
- NLY $2.00
- P/E Ratio
- COO $33.09
- NLY $20.57
- Revenue Growth
- COO 6.88
- NLY N/A
- 52 Week Low
- COO $65.00
- NLY $16.60
- 52 Week High
- COO $112.38
- NLY $22.11
- Technical
- Relative Strength Index (RSI)
- COO 38.32
- NLY 63.21
- Support Level
- COO $68.95
- NLY $20.21
- Resistance Level
- COO $71.61
- NLY $21.00
- Average True Range (ATR)
- COO 1.42
- NLY 0.37
- MACD
- COO -0.40
- NLY 0.03
- Stochastic Oscillator
- COO 6.57
- NLY 85.62
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
About NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.